Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature
infants. Despite improvements in neonatal care and management guidelines, ROP remains …

Abnormal blood vessel growth in the retina is a hallmark of many retinal diseases, such as
retinopathy of prematurity (ROP), proliferative diabetic retinopathy, and the wet form of age …

PURPOSE: To determine the incidence of retinopathy of prematurity (ROP) based on a
national database and to identify baseline characteristics, demographic information …

Ischaemic vascular disease in the retina may either leave retina permanently ischaemic with
slow degradation of vision, or alternatively lead to proliferative vascular disease, which can …

Purpose One goal of the study was to identify “new” statistically independent risk factors for
treatment-demanding retinopathy of prematurity (ROP). Another goal was to evaluate …

PURPOSE: To investigate the effectiveness and complications associated with the use of
bevacizumab, an anti–vascular endothelial growth factor agent, in the treatment of …

Aims To determine the incidence of retinopathy of prematurity (ROP) based upon a national
database and to identify baseline characteristics, demographic information, comorbidities …

Retinopathy of prematurity (ROP) is an evolutive and potentially blinding eye disease that
affects preterm newborns. Unfortunately, until now no conservative therapy of active ROP …

Retinopathy of prematurity (ROP) is a retinal vasoproliferative disorder that represents an
important cause of childhood visual impairment and blindness. Although oxidative stress …

Background Improved survival of preterm neonates has increased the incidence of
retinopathy of prematurity (ROP) in many middle-income countries. Aim This study aimed to …